Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hyperphagia 4Short Bowel Syndrome 2Pena Shokeir syndrome, type 1 2Sepsis 1Neoplasms 1Malnutrition 1Inflammation 1Infections 1Ileus 1Bites and Stings 1Advanced Malignant Neoplasm 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms × soybean oil, phospholipid emulsion × Clear all
NCT01943409 2025-02-03

Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils

University Health Network, Toronto

Phase 4 Completed
303 enrolled 16 charts

Bites and Stings, Hyperphagia, Infections, Inflammation, Neoplasms, Sepsis, Malnutrition, Ileus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡